Disclosed herein is a stable injectable formulation comprising combination of Citicoline and Edaravone along with Cyclodextrin derivative, useful for the treatment of CNS disorders and ischemic strokes and further discloses a process of preparation of the said formulation.

The present invention describes an improved and industrially adoptable process for the synthesis of Pyrazolone derivatives of formula (I), having high purity. wherein, R1, R2, R3 are same or different, R1, R2, R3 constitute hydrogen, hydroxyl, nitro, amino, substituted amino, sulphonyl or substituted sulphonyl, ...

A stable lyophilized composition of Ixabepilone in amorphous form ready for reconstitution and administration through an infusion is disclosed. A process for preparation of lyophilized composition of Ixabepilone using citrate buffer along with the organic solvent in the range of 70:30 to 50:50 using commercially ava...

ABSTRACT Novel Composition of Enzalutamide Oral Dosage Form and Method of Manufacturing Thereof The present invention relates to novel composition of oral dosage forms of enzalutamide with pharmaceutically acceptable excipients and method of manufacturing thereof. The invention provides economical and advanced...

The present invention relates to a pharmaceutical composition of Rivaroxaban and mainly improved processes for preparing thereof in the form of a tablet or a capsule. A dissolution rate is obtained using these improved processes is very high. These improved dissolution helps the drug to reach at the absorption site ...

ABSTRACT Novel Composition of Lapatinib of Oral Solid Dosage Form and Method of Manufacturing Thereof The present invention discloses a novel pharmaceutical composition of lapatinib or a pharmaceutically acceptable salt thereof preferably oral solid dosage form of a tablet with pharmaceutically acceptable exci...

“ORAL FORMULATIONS OF EDARAVONE AND METHOD OF MANUFACTURING THEREOF” The present invention relates to oral suspension dosage form of Edaravone. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing marketed dosage form. Moreover, the solubility and ...

ABSTRACT "ORAL SOLID PHARMACEUTICAL COMPOSITION OF LENVATINIB MESYLATE AND METHOD OF MANUFACTURING THEREOF" The present invention discloses an oral pharmaceutical composition of Lenvatinib or a pharmaceutically acceptable salt thereof preferably oral solid dosage form of a capsule with pharmaceutically accepta...

“NOVEL COMPOSITION OF RUCAPARIB OF ORAL SOLID DOSAGE FORM AND METHOD OF MANUFACTURING THEREOF” The present invention discloses a novel pharmaceutical composition of Rucaparib or a pharmaceutically acceptable salt thereof preferably oral solid dosage form with pharmaceutically acceptable excipients using wet-granu...

ABSTRACT “NOVEL TOPICAL PHARMACEUTICAL COMPOSITIONS OF OZENOXACIN” The present invention discloses a novel topical pharmaceutical composition of Ozenoxacin specifically in cream form and method of preparation thereof. The pharmaceutical composition of present invention comprises Ozenoxacin with one or more nov...

“ORAL EFFERVESCENT COMPOSITION OF METFORMIN HYDROCHLORIDE & METHOD OF MANUFACTURING THEREOF” The present invention relates to an oral effervescent composition of Metformin hydrochloride. The invention also relates to providing stable, moisture controlled, technically advanced fixed dosage form over existing markete...

ABSTRACT “HIGH DOSAGE STRENGTH ORAL FORMULATIONS OF FAVIPIRAVIR AND METHOD OF MANUFACTURING THEREOF” The present invention relates to a high dosage strength pharmaceutical oral composition of Favipiravir with pharmaceutically acceptable salts thereof and improved processes for preparing thereof. The present in...

ABSTRACT “NOVEL FAVIPIRAVIR PARENTERAL COMPOSITIONS AND METHOD OF MANUFACTURING THEREOF” The present invention relates to a novel parenteral pharmaceutical composition of Favipiravir or a pharmaceutically acceptable salt thereof. The present invention provides more stable composition in more efficient way to pro...

“ORAL FORMULATIONS OF NINTEDANIB AND METHOD OF MANUFACTURING THEREOF” The present invention relates to an oral soft-gelatin capsule dosage form of Nintedanib and pharmaceutically acceptable salt thereof. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over ...

“ORAL FORMULATIONS OF EDARAVONE AND METHOD OF MANUFACTURING THEREOF” The present invention relates to oral dosage form of Edaravone. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing marketed dosage form. The present invention further relates to...

The present invention relates to oral suspension and/ or capsule dosage form of Paclitaxel and pharmaceutically acceptable excipients thereof. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing marketed dosage form as well as nearest prior-arts. Mor...

The present invention relates to sublingual dosage forms of Everolimus and pharmaceutically acceptable salt thereof. The present invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing marketed dosage form as well as nearest prior-arts which are mentioned in...

The present invention relates to oral formulations of Bempedoic Acid or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient wherein intra-granular part is not free of lubricants. Further, the invention relates to providing an economical and technically advanced dosage form ...

“NOVEL ORAL LIQUID COMPOSITIONS OF ENZALUTAMIDE AND METHOD OF MANUFACTURING THEREOF” The present invention relates to oral liquid formulations of Enzalutamide or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. Further, the invention relates to providing an economica...

The present invention relates to oral suspension dosage form of Abiraterone Acetate. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing dosage form. Moreover, the solubility and stability of the patient compliant Abiraterone Acetate formulation, pre...

ORAL FORMULATIONS OF EDARAVONE AND IMPROVED METHOD OF MANUFACTURING THEREOF The present invention relates to a powder for oral suspension dosage form of Edaravone. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing dosage form. Moreover, the solu...

SOLID ORAL COMPOSITION OF OLAPARIB AND ITS SALTS THEREOF The present invention discloses a novel solid oral pharmaceutical composition of olaparib or pharmaceutically acceptable salts thereof in the solid oral dosage form preferably in the form of a tablet and its process for preparations thereof. The present inven...

“A PROCESS FOR THE PREPARATION OF LUMATEPERONE” The present invention relates a novel process for the preparation lumateperone of formula I, pharmaceutically acceptable salts thereof via novel intermediates. Over and above that, the present invention relates to providing an economical and technically facile proce...

AN ORAL SOLID PHARMACEUTICAL FORMULATION OF ENZALUTAMIDE The present invention relates to novel oral solid pharmaceutical formulation of enzalutamide or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. An enzalutamide pharmaceutical formulation comprising a one or more...

ABSTRACT HIGH DOSAGE STRENGTH OF AMPHOTERICIN B LIPOSOME The present invention relates to a novel high volume and strength parenteral pharmaceutical composition of Liposomal Amphotericin B or a pharmaceutically acceptable salt thereof.

ABSTRACT PHARMACEUTICAL COMPOSITION OF RELUGOLIX TABLET The present invention relates to novel oral solid pharmaceutical formulation of relugolix or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. In addition, the present invention also provides an improved process...

The present invention relates to oral pharmaceutical suspension dosage form of Lapatinib and process of manufacturing thereof. The invention relates to providing patient-compliant, economical and technically advanced dosage form over existing dosage form.